AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrosis 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Siskan Pharma

Salt Composition

Letrozole (2.5mg)

Overview Letrosis 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letrosis 2.5mg tablets. This medication can be a standalone treatment or used in conjunction with other therapies like surgery or radiotherapy. It's also indicated for advanced breast cancer, aiming to inhibit metastasis. Letrosis 2.5mg tablets may be ingested with or without food, always following your physician's prescribed dosage and regimen for optimal efficacy. Dosage adjustments depend on individual needs and the specific condition being treated; your doctor will determine the appropriate amount to manage your symptoms. Continuous use, as directed, is crucial. Common side effects include increased sweating, fatigue, hot flushes, and elevated cholesterol (hypercholesterolemia). Report any concerning or persistent side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as drug interactions may impact Letrosis's effectiveness. Disclose your pregnancy or breastfeeding status. Your doctor may order blood tests to monitor vitamin D levels and bone density both before and throughout the treatment course.

Uses of Letrosis 2.5mg Tablet

Managing Breast Cancer

Major Benefits of Letrosis 2.5mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Letrosis tablet whole; do not crush, chew, or divide it. While it can be taken with or without food, consistent timing is recommended.

Common Side effects of Letrosis 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrosis 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2.5mg Letrosis Tablet whole; avoid chewing, crushing, or breaking it. It can be taken with or without food, but consistent timing is recommended.

How Letrosis 2.5mg Tablet works:

Letrosis 2.5mg tablets are aromatase inhibitors that reduce the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingesting alcohol alongside Letrosis 2.5mg tablets presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Using Letrosis 2.5mg tablets during pregnancy carries a high risk. Pregnant women should consult their physician; research in animal and human studies indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Administering Letrosis 2.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingUNSAFE

Taking a Letrosis 2.5mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease may safely use Letrosis 2.5mg tablets without dosage modification. However, data on its use in end-stage kidney disease is scarce; physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letrosis 2.5mg tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Letrosis 2.5mg Tablet :

For Letrosis 2.5mg Tablets, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letrosis 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Letrosis 2.5mg Tablet

Letrosis 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrozole 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen, thus lowering estrogen levels. This is beneficial because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lower estrogen levels can therefore help prevent cancer growth.
For advanced breast cancer or cancer that has spread, continue Letrosis 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letrosis 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letrosis 2.5mg Tablet followed by three years of tamoxifen may be used.
It's safe to combine irbesartan with Letrosis 2.5mg, but monitor your blood pressure closely as Letrosis 2.5mg can elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrosis 2.5mg Tablets may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Letrosis 2.5mg tablets can sometimes cause hot flushes, a common side effect resulting from decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment and subside a few months afterward. If hot flushes are severe, consult your doctor for relief.
While rare, serious side effects of Letrosis 2.5mg Tablet may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrosis 2.5mg Tablets can lead to bone thinning (osteoporosis) from reduced estrogen. Your doctor may monitor your bone density before, during, and after treatment to check for this.
The Ministry of Health and Family Welfare restricts Letrosis 2.5mg Tablets to inducing ovulation in women with anovulatory infertility.
Letrosis 2.5mg Tablet
137
MRP 159
13% off